Stockholders’ Deficiency

3 Months Ended

Mar. 31, 2025

Equity [Abstract]

Stockholders’ Deficiency

11. Stockholders’ Deficiency

The Company has the authority to issue 1,000,000,000 shares of common stock, $0.01 par value per share.

Restricted Stock Units – The Company issued, in connection with the vesting of restricted stock units, 7,499 and 678,165 shares of the Company’s common stock during the three months ended March 31, 2025 and 2024, respectively, as reflected on the condensed consolidated statements of stockholders’ deficiency.

Common Stock Withheld – The Company recorded the repurchase of 2,814 shares related to vested restricted stock units for the payment for taxes of $4, and 282,171 shares related to vested restricted stock units for the payment for taxes of $479, during the three months ended March 31, 2025 and 2024, respectively, as reflected on the consolidated statements of stockholders’ deficiency.

Common Stock Private Placement – On February 14, 2024, the Company entered into a subscription agreement (the “Subscription Agreement”) with Simplify, pursuant to which the Company agreed to sell and issue to Simplify in a private placement (the “Private Placement”) an aggregate of 5,555,555 shares (the “Private Placement Shares”) of the Company’s common stock, at a purchase price of $2.16 per share, a price equal to the 60-day volume weighted average price of the Company’s common stock. The Private Placement closed on February 14, 2024 and the Company received proceeds from the Private Placement of $12,000 as reflected on the condensed consolidated statements of stockholders’ deficiency. Further information is provided in Note 15.